.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Targeting KRAS Mutations: A Novel Approach in Advanced NSCLC

EP. 1: Current Management of Oncogene-Driven NSCLC

August 3rd 2020

EP. 2: KRAS Mutations in Solid Tumors

August 3rd 2020

EP. 3: Testing for KRAS Mutations in NSCLC

August 3rd 2020

EP. 4: Counseling Patients With NSCLC When KRAS is Detected

August 3rd 2020

EP. 5: Systemic Therapy for KRAS+ Advanced NSCLC

August 3rd 2020

EP. 6: Development of KRAS G12C-Targeted Therapy in NSCLC

August 3rd 2020

EP. 7: KRAS G12C Inhibition in Advanced NSCLC: AMG 510

August 3rd 2020

EP. 8: KRAS G12C Inhibition in Advanced NSCLC: MRTX849

August 3rd 2020